Author:
King Franklin G.,Dedrick Robert L.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics
Reference24 articles.
1. P. W. K. Woo, H. W. Dion, S. M. Lange, L. F. Dahl, and L. J. Durham. A novel adenosine and ara-A deaminase inhibitor, (R)-3-(2-deoxy-beta-D-erythropen- tofuranosyl)-3,6,7,8-tetrahydroimidazo(4,5-d)(1,3) diazepin-8-ol.J. Heterocyclic. Chem. 11:641–643 (1974).
2. R. P. Agarwal, T. Spector, and R. E. Parks, Jr. Tight binding inhibitors-IV. Inhibition of adenosine deaminases by various inhibitors.Biochem. Pharmacol. 26:359–367 (1977).
3. G. A. LePage, L. S. Worth, and A. P. Kimball. Enhancement of the antitumor activity of arabinofuranosyladenine by 2′-deoxycoformycin.Cancer Res. 36:1481–1485 (1976).
4. T. G. Brady and C. I. O'Donovan. A study of the tissue distribution of adenosine deaminase in six mammal species.Comp. Biochem. Physiol. 14:101–120 (1965).
5. S. H. Lee, N. Caron, and A. P. Kimball. Therapeutic effects of 9-B-D-arabinofuranosyladenine and 2′-deoxycoforrnycin combinations on intracerebral leukemia.Cancer Res. 37:1953–1955 (1977).
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献